Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Johnson & Johnson (JNJ) beats Wall Street estimates on strong drug sales in the second quarter, driving profit growth. The company announces its Q2 2024 earnings results, with CEO highlighting strong sales and earnings per share growth.
Johnson & Johnson tops Wall Street estimates on strong drug sales https://t.co/v5TkEijpVP
☀️ FSMN MORNING NEWS SUMMARY - JULY 17, 2024☀️ peek of morning news summaries for subs ⬛️ Top News • $JNJ Beats Wall Street Estimates on Strong Drug Sales: Johnson & Johnson reported strong sales of its drugs, including Darzalex and Stelara, driving second-quarter profit and…
$JNJ CFO Joe Wolk breaks down the company's better-than-expected Q2 earnings, and explains why it's lowering guidance: https://t.co/KXzf0dIjaM